Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Guardant Health

Guardant Health (NASDAQ: GH) insider transactions

In the twelve months to 10 November 2026, executives and directors of Guardant Health reported 141 open-market sales of 1,386,462 shares ($172.9m) and 1 open-market purchase of 600 shares ($78,456), by 15 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Guardant Health shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
21 October 2026Mignone RobertoDirectorOption exercise+264—10,538Form 4
17 October 2026Hidalgo Medina ManuelDirectorOption exercise+232—5,252Form 4
16 October 2026Tariq MusaDirectorOpen-market sale, 10b5-1 plan−116$165.8811,583Form 4
15 October 2026Tariq MusaDirectorOption exercise, 10b5-1 plan+250—11,699Form 4
14 October 2026Azar Alex M IIDirectorOpen-market sale, 10b5-1 plan−69$159.89893Form 4
12 October 2026Azar Alex M IIDirectorOption exercise+137—962Form 4
1 October 2026Monroe Terilyn J.Chief People OfficerOption exercise+2,659—25,638Form 4
1 October 2026Monroe Terilyn J.Chief People OfficerOption exercise+1,360—26,998Form 4
1 October 2026Monroe Terilyn J.Chief People OfficerShares withheld for tax−2,098$174.7524,900Form 4
1 October 2026Bell Michael BrianChief Financial OfficerOption exercise+2,085—53,901Form 4
1 October 2026Bell Michael BrianChief Financial OfficerOption exercise+3,324—57,225Form 4
1 October 2026Bell Michael BrianChief Financial OfficerOption exercise+1,871—59,096Form 4
1 October 2026Bell Michael BrianChief Financial OfficerShares withheld for tax−3,914$174.7555,182Form 4
1 October 2026Saia John G.Chief Legal OfficerOption exercise+974—39,965Form 4
1 October 2026Saia John G.Chief Legal OfficerOption exercise+1,668—41,633Form 4
1 October 2026Saia John G.Chief Legal OfficerOption exercise+2,925—44,558Form 4
1 October 2026Saia John G.Chief Legal OfficerOption exercise+1,496—46,054Form 4
1 October 2026Saia John G.Chief Legal OfficerShares withheld for tax−3,706$174.7542,348Form 4
1 October 2026Eltoukhy HelmyCo-Chief Executive OfficerOption exercise+23,997—1,966,320Form 4
1 October 2026Eltoukhy HelmyCo-Chief Executive OfficerOption exercise+9,716—1,976,036Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Guardant Health page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.